Pediatricians must be able to identify emergent neurologic problems when they present in the office or are suspected in children and proceed with appropriate workup and treatment.
Neural performance scanning technology outperforms photoscreeners for analyzing binocularity in a child’s eyes in mere seconds, and with higher sensitivity and specificity.
Pediatric drug development has made exceptional strides in the last 10 years. The outlook going forward is remarkably positive, but new pressures to expedite the process are emerging.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%